Menu Search
Equities

Fonar Corp

FOAA:FRA

Fonar Corp

Actions
  • Price (EUR)14.30
  • Today's Change-0.300 / -2.05%
  • Shares traded-1.00
  • 1 Year change-6.54%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

FONAR Corporation is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging scanners, MRI, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries. The Company conducts its business in two segments. The medical equipment segment is conducted directly through FONAR. The physician management and diagnostic services segment is conducted through its subsidiary Health Management Corporation of America (HMCA). HMCA provides management services, administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing, information technology (IT) services, hiring, conducting interviews and managing personnel, storage of medical records, office space, equipment, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging.

  • Revenue in USD (TTM)102.72m
  • Net income in USD10.29m
  • Incorporated1978
  • Employees561.00
  • Location
    Fonar Corp110 Marcus DrMELVILLE 11747-4228United StatesUSA
  • Phone+1 (631) 694-2929
  • Fax+1 (631) 753-5150
  • Websitehttp://www.fonar.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.